Founder & CEO

Chief Innovation Officer

Topical Drugs CDMO Market Size to Expand USD 136.71 Billion by 2034

Absci in GenAI Drug Discovery Collaboration with Oracle and AMD

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci accelerates AI-driven drug discovery with Oracle and AMD

General Interest

Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. They are always on the lookout for extraordinary talent to help redefine the boundaries of science and innovation, encouraging candidates to submit general applications for future opportunities.

Sign up with Google

Sign in with Google